Bloomberg Law
Business & Practice
LinkedIn

Failed Deals, Legal Risks Sink Rite Aid Into Distress: The Brink

April 11, 2023, 4:07 PM UTC
Diana Li
Diana Li

Welcome to The Brink. I’m Diana Li, a reporter in New York, where we’re taking a closer look at the future of pharmacy chain Rite Aid. We also have the latest on Tupperware and Serta Simmons. Follow this link to subscribe. Send us feedback and tips at dli631@bloomberg.net or Tweet/DM to @diana_k16.

Drugstore Troubles

It was almost a year ago that Rite Aid turned down a buyout offer from a hedge fund. The price dangled that day for the drugstore chain: $14.60 per share.

Today the stock trades around $2.50, the company is battling opioid-linked litigation ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.